Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas
Brain Tumor Pathology · 2004-10 · 21 (3) · 113-116
DOI: 10.1007/bf02482185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Tumor Pathology, 2004-10. Verfasst von Yukiko Nakahara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan. nakahara@post.saga-med.ac.jp. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan. nakahara@post.saga-med.ac.jp
Zitieren
APA
Nakahara, Y., Okamoto, H., Mineta, T., & Tabuchi, K. (2004). Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas. Brain Tumor Pathology, 21(3), 113-116. https://doi.org/10.1007/bf02482185
Vancouver
Nakahara Y, Okamoto H, Mineta T, Tabuchi K. Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas. Brain Tumor Pathology. 2004;21(3):113-116. doi:10.1007/bf02482185
BibTeX
@article{Nakahara2004,
author = {Nakahara, Yukiko and Okamoto, Hiroaki and Mineta, Toshihiro and Tabuchi, Kazuo},
title = {Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas},
journal = {Brain Tumor Pathology},
year = {2004},
volume = {21},
number = {3},
pages = {113--116},
doi = {10.1007/bf02482185}
}
EUVIMED